Trials / Completed
CompletedNCT02626780
Adipose-derived SVF for Treatment of Alopecia
Adipose-derived Stromal Vascular Fraction (SVF) Injections to Stimulate Hair Regrowth for Androgenetic Alopecia
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 7 (actual)
- Sponsor
- GID BIO, Inc. · Industry
- Sex
- All
- Age
- 18 Years – 60 Years
- Healthy volunteers
- Accepted
Summary
The general objective of this study is to conduct a safety and feasibility study of a single injection of autologous adipose-derived SVF for the treatment of alopecia.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | GID SVF-2 | Comparison of the number of hairs before and after treatment of autologous adipose-derived SVF as a percentage increase or decrease in growth. |
Timeline
- Start date
- 2016-07-20
- Primary completion
- 2017-01-22
- Completion
- 2017-01-22
- First posted
- 2015-12-10
- Last updated
- 2019-03-21
- Results posted
- 2019-03-21
Locations
2 sites across 1 country: United States
Source: ClinicalTrials.gov record NCT02626780. Inclusion in this directory is not an endorsement.